Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Fecal microbiome transplant shows favorable safety profile in HIV-infected subjects

Oct. 21, 2015

Shionogi introduces anti-HIV agents

Oct. 19, 2015

ViroCarb divulges HIV viral entry inhibitors

Oct. 16, 2015

Institute of Human Virology begins phase I trial of HIV vaccine candidate

Oct. 15, 2015

Merck & Co. reports HIV reverse transcriptase inhibitors

Oct. 15, 2015

Merck & Co. initiates phase I trial of MK-8591 for HIV-1 infection

Oct. 7, 2015

Merck & Co. and Merck Frosst Canada report HIV protease inhibitors

Sep. 30, 2015

CHMP adopts positive opinion on Gilead's Genvoya for HIV infection

Sep. 28, 2015

Merck & Co. unveils HIV protease inhibitors

Sep. 25, 2015

Artificially designed peptide inhibits HIV fusion with improved pharmacological properties

Sep. 22, 2015

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...